ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ANIP on Nasdaq
CUSIP
00182C103
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
22.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
20.4M
Holdings value
$1.87B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
264
Number of buys
142
Number of sells
-106
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11.3% $231M 2.52M BlackRock, Inc. Sep 30, 2025
Meridian Venture Partners II GP, L.P. 4.8% -12% $95.1M -$13.8M 1.03M -12.7% Robert E. Brown, Jr. Aug 21, 2025
MILLENNIUM MANAGEMENT LLC 3.8% -28% $51.6M -$17.2M 818K -25% Millennium Management LLC Mar 31, 2025
INTEGRATED CORE STRATEGIES (US) LLC 0.3% -98% $5.98M -$96.3M 65.2K -94.2% Millennium Management LLC Sep 30, 2025

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 20.4M $1.87B +$53.6M $91.60 264
2025 Q2 19.7M $1.29B -$20.1M $65.25 229
2025 Q1 19.9M $1.33B +$48.4M $66.95 225
2024 Q4 19.3M $1.07B +$20.4M $55.28 204
2024 Q3 18.9M $1.13B +$221M $59.66 207
2024 Q2 15.1M $963M +$64.7M $63.68 200
2024 Q1 14.1M $974M +$35.9M $69.13 195
2023 Q4 5.77K $318K -$1.24M $55.14 1
2023 Q3 13.2M $765M +$50.1M $58.06 183
2023 Q2 12.3M $661M +$105M $53.83 167
2023 Q1 10.3M $411M +$7.05M $39.72 136
2022 Q4 10.2M $412M +$3.08M $40.23 124
2022 Q3 10.3M $330M +$12.8M $32.14 114
2022 Q2 9.85M $293M +$29.9M $29.67 107
2022 Q1 9.17M $258M -$5.7M $28.11 112
2021 Q4 8.88M $409M +$81.9M $46.08 121
2021 Q3 7.27M $239M +$15.3M $32.82 106
2021 Q2 7.21M $253M -$2.82M $35.05 107
2021 Q1 7.29M $263M -$828K $36.14 101
2020 Q4 7.31M $212M +$2.53M $29.04 107
2020 Q3 7.26M $205M -$7.68M $28.21 102
2020 Q2 7.27M $235M -$25.7M $32.34 118
2020 Q1 7.94M $323M -$12.4M $40.74 133
2019 Q4 8.07M $498M -$71M $61.67 160
2019 Q3 9.1M $663M +$37.9M $72.88 179
2019 Q2 8.56M $704M +$78.9M $82.20 188
2019 Q1 7.47M $527M +$37.9M $70.54 180
2018 Q4 7.08M $319M -$17.8M $45.02 155
2018 Q3 7.46M $422M +$13.6M $56.54 162
2018 Q2 7.18M $480M +$21M $66.80 177
2018 Q1 6.62M $386M +$5.07M $58.22 165
2017 Q4 6.54M $422M +$7.87M $64.45 151
2017 Q3 6.39M $335M -$1.91M $52.49 133
2017 Q2 6.42M $302M +$685K $46.80 141
2017 Q1 6.44M $319M +$59.8M $49.51 149
2016 Q4 6.24M $378M +$11.1M $60.62 147
2016 Q3 5.98M $397M +$26.7M $66.35 162
2016 Q2 5.6M $312M +$11.6M $55.82 133
2016 Q1 5.8M $195M -$21.5M $33.66 114
2015 Q4 6.32M $285M -$30.5M $45.12 119
2015 Q3 6.97M $275M +$16.6M $39.51 118
2015 Q2 6.39M $396M -$29.9M $62.05 118
2015 Q1 6.96M $435M +$84.6M $62.55 127
2014 Q4 5.63M $317M +$99.2M $56.39 99
2014 Q3 4.53M $129M -$3.21M $28.28 69
2014 Q2 4.49M $155M +$28.4M $34.44 78
2014 Q1 3.76M $118M +$77.6M $31.35 64